Primary Progressive Aphasia Clinical Trial
Official title:
Baseline Performance Predicts tDCS-mediated Improvements in Language Symptoms in Primary Progressive Aphasia
In the present sham-controlled study, the investigators examine whether tDCS could be used to enhance language abilities (e.g., picture naming) in individuals with primary progressive aphasia (PPA) primarily characterized by difficulties with speech production.
Primary Progressive Aphasia (PPA) is a neurodegenerative condition characterized by insidious irreversible loss of language abilities. Prior studies suggest that transcranial direct current stimulation (tDCS) directed toward language areas of the brain may help to ameliorate symptoms of PPA. In the current study, the investigators are examining whether tDCS could be used to enhance language abilities (e.g., picture naming) in individuals with PPA variants primarily characterized by difficulties with speech production (non-fluent and logopenic). Participants are being recruited from the Penn Frontotemporal Dementia Center to receive 10 days of both real and sham tDCS (counter-balanced, full-crossover design; participants are naïve to stimulation condition). A battery of language tests are being administered at baseline, immediately post-tDCS (real and sham), and six weeks and twelve weeks following stimulation. Real tDCS may improve language performance in some individuals with PPA. Specifically, the investigators expect that tDCS will be more effective in people whose baseline performance is worse based on previous research. Severity of deficits at baseline may be an important factor in predicting which patients will respond positively to language-targeted tDCS therapies. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT04290988 -
Circuitry Assessment and Reinforcement Training Effects on Recovery
|
N/A | |
Recruiting |
NCT04957537 -
Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia
|
N/A | |
Completed |
NCT04045990 -
Network Modulation in Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05443633 -
Enhancing Language Function in Aphasia
|
N/A | |
Completed |
NCT05860647 -
Transmagnetic Stimulation Pilot in Primary Progressive Aphasia
|
N/A | |
Recruiting |
NCT03887481 -
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
|
N/A | |
Completed |
NCT03728582 -
Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy
|
N/A | |
Completed |
NCT01465360 -
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
|
N/A | |
Completed |
NCT02541097 -
Preventing Language Decline in Dementia
|
N/A | |
Recruiting |
NCT00537004 -
Language in Primary Progressive Aphasia
|
||
Recruiting |
NCT05741853 -
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
|
N/A | |
Active, not recruiting |
NCT05742698 -
Nabilone for Agitation in Frontotemporal Dementia
|
Phase 2 | |
Completed |
NCT02439853 -
Communication Bridge Speech Therapy Research Study
|
N/A | |
Completed |
NCT01623284 -
PiB PET Scanning in Speech and Language Based Dementias
|
Phase 1 | |
Completed |
NCT04726527 -
Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
|
||
Completed |
NCT03076671 -
More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
|
N/A | |
Completed |
NCT05537688 -
Identification of Graphic Markers of Neurocognitive Disorders (MG)
|
||
Completed |
NCT05525377 -
Better Living With Non-memory-led Dementia
|
N/A | |
Completed |
NCT04939818 -
Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders
|
||
Enrolling by invitation |
NCT05368350 -
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
|
Early Phase 1 |